Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
Sylvamo
SLVM
$1.45B
| $501K | ﹤0.01% |
12,383
-200,539
| -94% | -$8.66M |
|
|
RNAM
4477
DELISTED
Avidity Biosciences
RNAM
| $501K | ﹤0.01% |
+45,140
| New | +$566K |
|
4478
PUT
Icon
ICLR
$13.1B
| $500K | ﹤0.01% |
2,000
-3,000
| -60% | -$637K |
|
4479
Unity Bancorp
UNTY
$591M
| $500K | ﹤0.01% |
21,202
-4,786
| -18% | -$109K |
|
4480
PUT
Vaxcyte
PCVX
$8.92B
| $499K | ﹤0.01% |
+10,000
| New | +$474K |
|
|
HUT
4481
Hut 8
HUT
$9.78B
| $499K | ﹤0.01% |
30,052
-21,236
| -41% | -$218K |
|
4482
TriplePoint Venture Growth BDC
TPVG
$221M
| $499K | ﹤0.01% |
42,361
+25,293
| +148% | +$286K |
|
4483
Vanguard FTSE Developed Markets ETF
VEA
$238B
| $499K | ﹤0.01% |
10,800
-16,740
| -61% | -$770K |
|
4484
CALL
XPeng
XPEV
$11B
| $498K | ﹤0.01% |
37,100
+18,900
| +104% | +$186K |
|
4485
James Hardie Industries
JHX
$17.4B
| $498K | ﹤0.01% |
+18,506
| New | +$447K |
|
|
LGF.A
4486
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $497K | ﹤0.01% |
56,332
+30,506
| +118% | +$321K |
|
|
DOC
4487
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $497K | ﹤0.01% |
+35,528
| New | +$505K |
|
|
LBC
4488
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $496K | ﹤0.01% |
+55,648
| New | +$504K |
|
|
DCFC
4489
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| $495K | ﹤0.01% |
2,271
-545
| -19% | -$118K |
|
|
IVAC
4490
DELISTED
Intevac Inc
IVAC
| $495K | ﹤0.01% |
131,887
-140,430
| -52% | -$753K |
|
|
WE
4491
DELISTED
WeWork Inc.
WE
| $495K | ﹤0.01% |
58,775
-2,377
| -4% | -$32.9K |
|
4492
CALL
Opendoor
OPEN
$3.2B
| $492K | ﹤0.01% |
126,583
+15,293
| +14% | +$33.2K |
|
|
OMGA
4493
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $492K | ﹤0.01% |
87,897
-125,893
| -59% | -$985K |
|
4494
BayCom
BCML
$331M
| $491K | ﹤0.01% |
29,463
-22,410
| -43% | -$370K |
|
4495
CALL
Tandem Diabetes Care
TNDM
$1.49B
| $491K | ﹤0.01% |
+20,000
| New | +$643K |
|
|
4496
PUT
Tandem Diabetes Care
TNDM
$1.49B
| $491K | ﹤0.01% |
+20,000
| New | +$643K |
|
4497
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.6B
| $489K | ﹤0.01% |
15,242
-155,579
| -91% | -$5.02M |
|
4498
CALL
Ball Corp
BALL
$16.9B
| $489K | ﹤0.01% |
+8,400
| New | +$455K |
|
4499
CALL
Manchester United
MANU
$3.8B
| $488K | ﹤0.01% |
20,000
-128,400
| -87% | -$2.66M |
|
|
BGRYW
4500
CALL
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
| $487K | ﹤0.01% |
1,453,464
+324,703
| +29% | +$106K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.